The present study aimed to evaluate and compare the proliferative activity using Ki-67 labelling index (LI) among solid/multicystic ameloblastoma (SMA), unicystic ameloblastoma (UA), and desmoplastic ameloblastoma (DA), and to correlate the findings with their known clinical aggressiveness and recurrence potential. This evidence concerns the gene MKI67 and ameloblastoma.